A Population-Based Study of Bacterial Spectrum in Febrile Neutropenic Patients
暂无分享,去创建一个
[1] M. Meidani,et al. Blood Culture in Neutropenic Patients with Fever , 2012, International journal of preventive medicine.
[2] S. Kim,et al. Evidence-Based Guidelines for Empirical Therapy of Neutropenic Fever in Korea , 2011, The Korean journal of internal medicine.
[3] K. Sepkowitz,et al. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 Update by the Infectious Diseases Society of America. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[4] J. D. Camargo. Brazilian experience with the medium-term multi-organ bioassay: scientific and regulatory developments. , 2010 .
[5] Z. M. Yusoff,et al. Fever/clinical signs and association with neutropenia in solid cancer patients--bacterial infection as the main cause. , 2010, Asian Pacific journal of cancer prevention : APJCP.
[6] H. Hafeez,et al. Bacterial spectrum and susceptibility patterns of pathogens in adult febrile neutropenic patients: a comparison between two time periods. , 2009, Journal of Ayub Medical College, Abbottabad : JAMC.
[7] M. Anwar,et al. BACTERIAL PATHOGENS RESPONSIBLE FOR BLOOD STREAM INFECTION (BSI) AND PATTERN OF DRUG RESISTANCE IN A TERTIARY CARE HOSPITAL OF LAHORE , 2009 .
[8] R. Feld. Bloodstream infections in cancer patients with febrile neutropenia. , 2008, International journal of antimicrobial agents.
[9] G. Rossi,et al. Recent changes in bacterial epidemiology and the emergence of fluoroquinolone-resistant Escherichia coli among patients with haematological malignancies: results of a prospective study on 823 patients at a single institution. , 2008, The Journal of antimicrobial chemotherapy.
[10] H. Lyall,et al. HIV and mitochondrial toxicity in children. , 2007, The Journal of antimicrobial chemotherapy.
[11] C. Viscoli,et al. A prospective study on the epidemiology of febrile episodes during chemotherapy-induced neutropenia in children with cancer or after hemopoietic stem cell transplantation. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[12] M. Paesmans,et al. Bacteraemia in febrile neutropenic cancer patients. , 2007, International journal of antimicrobial agents.
[13] S. Kaya,et al. Comparison of the BACTEC blood culture system versus conventional methods for culture of normally sterile body fluids , 2007, Advances in therapy.
[14] S. Ritchie,et al. High‐risk febrile neutropenia in Auckland 2003–2004: the influence of the microbiology laboratory on patient treatment and the use of pathogen‐specific therapy , 2007, Internal medicine journal.
[15] D. Dzierżanowska,et al. [Infection in neutropenic cancer patients--etiology, microbiological diagnostics, treatment]. , 2006, Wiadomosci lekarskie.
[16] C. Viscoli,et al. Infections in patients with febrile neutropenia: epidemiology, microbiology, and risk stratification. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[17] J. D. Pabón,et al. El cambio climático y la salud humana , 2005 .
[18] E. Poveda,et al. Efecto del suplemento de aceites vegetales sobre el perfil lipídico en ratas wistar. , 2005 .
[19] Sanjib K. Sharma,et al. Melioidosis imported into Nepal , 2005, Scandinavian journal of infectious diseases.
[20] S. Harthug,et al. A multi-centre prospective study of febrile neutropenia in Norway: Microbiological findings and antimicrobial susceptibility , 2005, Scandinavian journal of infectious diseases.
[21] E. González-Barca,et al. Prospective study of 288 episodes of bacteremia in neutropenic cancer patients in a single institution , 1996, European Journal of Clinical Microbiology and Infectious Diseases.
[22] Yee-Chun Chen,et al. Trends and antimicrobial resistance of pathogens causing bloodstream infections among febrile neutropenic adults with hematological malignancy. , 2004, Journal of the Formosan Medical Association = Taiwan yi zhi.
[23] P. Breig,et al. Markers of bacteremia in febrile neutropenic patients with hematological malignancies: procalcitonin and IL-6 are more reliable than C-reactive protein , 2004, European Journal of Clinical Microbiology and Infectious Diseases.
[24] S. Chu,et al. Molecular epidemiology and control of nosocomial methicillin-resistant Staphylococcus aureus infection in a teaching hospital. , 2004, Journal of the Formosan Medical Association = Taiwan yi zhi.
[25] A. Mahmood,et al. Bloodstream infections in febrile neutropenic patients: bacterial spectrum and antimicrobial susceptibility pattern. , 2004, Journal of Ayub Medical College, Abbottabad : JAMC.
[26] R. Mohamed. Malays J Pathol , 2003 .
[27] R. Wenzel,et al. Current trends in the epidemiology of nosocomial bloodstream infections in patients with hematological malignancies and solid neoplasms in hospitals in the United States. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[28] M. Björkholm,et al. Bacteraemia in hospitalised patients with malignant blood disorders: a retrospective study of causative agents and their resistance profiles during a 14-year period without antibacterial prophylaxis. , 2003, The hematology journal : the official journal of the European Haematology Association.
[29] H. Groen,et al. Fever and neutropenia in cancer patients: the diagnostic role of cytokines in risk assessment strategies. , 2002, Critical reviews in oncology/hematology.
[30] J. Billé. Laboratory diagnosis of infections in febrile neutropenic or immunocompromised patients. , 2000, International journal of antimicrobial agents.
[31] S. Zinner. Changing epidemiology of infections in patients with neutropenia and cancer: emphasis on gram-positive and resistant bacteria. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[32] E. Kaiserova,et al. Bacteremia and fungemia in pediatric versus adult cancer patients after chemotherapy: comparison of etiology, risk factors and outcome. , 1998, Journal of chemotherapy.
[33] M. Paesmans,et al. A comparison of outcome from febrile neutropenic episodes in children compared with adults: results from four EORTC studies , 1997, British journal of haematology.
[34] N. Thanaletchimy,et al. Comparative study of a non-radiometric BACTEC system and a conventional blood culture system in a clinical microbiology laboratory. , 1995, The Malaysian journal of pathology.
[35] A. Pappo,et al. The changing epidemiology of bacteremia in neutropenic children with cancer. , 1995, The Pediatric infectious disease journal.
[36] A. Brown,et al. The changing epidemiology of infections at cancer hospitals. , 1993, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[37] W Satterlee,et al. Empiric therapy with carbenicillin and gentamicin for febrile patients with cancer and granulocytopenia. , 1971, The New England journal of medicine.